Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Monitoring, Ambulatory | 4 | 2011 | 354 | 0.340 |
Why?
|
Extracellular Fluid | 1 | 2011 | 165 | 0.340 |
Why?
|
Blood Glucose | 7 | 2011 | 6391 | 0.320 |
Why?
|
Benchmarking | 1 | 2011 | 1045 | 0.230 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2011 | 3415 | 0.230 |
Why?
|
Hepatitis C, Chronic | 4 | 2009 | 1032 | 0.180 |
Why?
|
Interview, Psychological | 1 | 2004 | 809 | 0.180 |
Why?
|
Medical Records | 1 | 2006 | 1408 | 0.170 |
Why?
|
Hospitals | 2 | 2011 | 3882 | 0.170 |
Why?
|
Guideline Adherence | 2 | 2008 | 2220 | 0.160 |
Why?
|
Glucose | 1 | 2011 | 4346 | 0.160 |
Why?
|
Hepacivirus | 4 | 2009 | 1336 | 0.160 |
Why?
|
Colorectal Neoplasms | 2 | 2011 | 6935 | 0.160 |
Why?
|
World Health Organization | 1 | 2004 | 1322 | 0.150 |
Why?
|
Antiviral Agents | 5 | 2009 | 3060 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2006 | 3514 | 0.140 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1988 | 0.140 |
Why?
|
Models, Statistical | 1 | 2011 | 5079 | 0.130 |
Why?
|
Antineoplastic Agents | 5 | 2011 | 13642 | 0.130 |
Why?
|
Pancreatectomy | 2 | 2010 | 811 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2011 | 12148 | 0.120 |
Why?
|
California | 2 | 2011 | 1430 | 0.120 |
Why?
|
Coronary Stenosis | 2 | 2011 | 794 | 0.110 |
Why?
|
Registries | 2 | 2011 | 8224 | 0.110 |
Why?
|
Mental Disorders | 2 | 2004 | 6845 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2006 | 625 | 0.110 |
Why?
|
Fatty Liver | 2 | 2012 | 790 | 0.110 |
Why?
|
Analgesia, Epidural | 1 | 2006 | 332 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2011 | 2297 | 0.100 |
Why?
|
Bayes Theorem | 3 | 2011 | 2330 | 0.100 |
Why?
|
Sampling Studies | 2 | 2004 | 615 | 0.100 |
Why?
|
Pancreatic Neoplasms | 4 | 2011 | 5369 | 0.100 |
Why?
|
Bronchial Provocation Tests | 1 | 2011 | 216 | 0.100 |
Why?
|
beta Karyopherins | 1 | 2011 | 46 | 0.100 |
Why?
|
Operating Room Information Systems | 1 | 2011 | 15 | 0.090 |
Why?
|
Ribavirin | 2 | 2009 | 395 | 0.090 |
Why?
|
Bronchoconstriction | 1 | 2011 | 142 | 0.090 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1459 | 0.090 |
Why?
|
Anesthesia Department, Hospital | 1 | 2011 | 69 | 0.090 |
Why?
|
Airway Resistance | 1 | 2011 | 406 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2011 | 20099 | 0.090 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2011 | 117 | 0.090 |
Why?
|
Matched-Pair Analysis | 1 | 2011 | 284 | 0.090 |
Why?
|
Epidemiologic Research Design | 2 | 2004 | 368 | 0.090 |
Why?
|
Adult | 33 | 2012 | 221203 | 0.090 |
Why?
|
Hepatitis C | 3 | 2009 | 1584 | 0.090 |
Why?
|
Amantadine | 1 | 2009 | 57 | 0.090 |
Why?
|
Nitrogen Radioisotopes | 1 | 2009 | 41 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2009 | 2651 | 0.080 |
Why?
|
Insulin Infusion Systems | 1 | 2011 | 217 | 0.080 |
Why?
|
Liver Cirrhosis | 3 | 2009 | 1935 | 0.080 |
Why?
|
Anesthesia | 2 | 2011 | 1595 | 0.080 |
Why?
|
Middle Aged | 32 | 2012 | 220920 | 0.080 |
Why?
|
Liver Neoplasms | 3 | 2011 | 4319 | 0.080 |
Why?
|
Mountaineering | 1 | 2008 | 45 | 0.080 |
Why?
|
alpha-Fetoproteins | 1 | 2009 | 223 | 0.080 |
Why?
|
Interferon-alpha | 2 | 2009 | 921 | 0.080 |
Why?
|
Virus Activation | 1 | 2010 | 322 | 0.080 |
Why?
|
Isoflurane | 1 | 2011 | 384 | 0.080 |
Why?
|
Ammonia | 1 | 2009 | 237 | 0.080 |
Why?
|
Postprandial Period | 1 | 2010 | 315 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 178 | 0.080 |
Why?
|
Aged | 26 | 2012 | 169310 | 0.080 |
Why?
|
Eyeglasses | 1 | 2009 | 137 | 0.080 |
Why?
|
Surgical Stapling | 1 | 2008 | 98 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2009 | 185 | 0.070 |
Why?
|
Tubulin | 1 | 2011 | 693 | 0.070 |
Why?
|
STAT1 Transcription Factor | 1 | 2009 | 341 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 2 | 2011 | 1192 | 0.070 |
Why?
|
Gallbladder Neoplasms | 1 | 2009 | 189 | 0.070 |
Why?
|
Pancreatic Fistula | 1 | 2008 | 148 | 0.070 |
Why?
|
Male | 36 | 2012 | 360842 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 694 | 0.070 |
Why?
|
Polyethylene Glycols | 2 | 2009 | 1189 | 0.070 |
Why?
|
GB virus C | 1 | 2006 | 9 | 0.070 |
Why?
|
Hepatitis B virus | 1 | 2010 | 528 | 0.070 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2008 | 197 | 0.070 |
Why?
|
Myopia | 1 | 2009 | 253 | 0.070 |
Why?
|
Anesthetics, Inhalation | 1 | 2011 | 574 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 746 | 0.070 |
Why?
|
Bronchi | 1 | 2010 | 845 | 0.070 |
Why?
|
Female | 35 | 2012 | 392686 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2010 | 402 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2010 | 410 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1740 | 0.060 |
Why?
|
Hepatitis, Viral, Human | 1 | 2006 | 141 | 0.060 |
Why?
|
Neurologic Examination | 1 | 2009 | 916 | 0.060 |
Why?
|
Adolescent | 11 | 2011 | 88324 | 0.060 |
Why?
|
Eye | 1 | 2009 | 712 | 0.060 |
Why?
|
Cholesterol, LDL | 2 | 2012 | 2382 | 0.060 |
Why?
|
Insulin | 2 | 2011 | 6597 | 0.060 |
Why?
|
Cataract Extraction | 1 | 2009 | 467 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6312 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2009 | 973 | 0.060 |
Why?
|
Trachea | 1 | 2010 | 1089 | 0.060 |
Why?
|
Adenosine | 1 | 2009 | 808 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1533 | 0.060 |
Why?
|
Aged, 80 and over | 12 | 2011 | 58986 | 0.060 |
Why?
|
Survival Analysis | 3 | 2011 | 10090 | 0.060 |
Why?
|
Humans | 41 | 2012 | 761572 | 0.050 |
Why?
|
Mathematical Computing | 1 | 2003 | 142 | 0.050 |
Why?
|
Kinetics | 1 | 2011 | 6374 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9177 | 0.050 |
Why?
|
Cause of Death | 2 | 2008 | 3683 | 0.050 |
Why?
|
Coronary Circulation | 1 | 2009 | 1569 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1833 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2009 | 6485 | 0.050 |
Why?
|
Exercise Test | 1 | 2011 | 2127 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1779 | 0.050 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1374 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2012 | 3575 | 0.050 |
Why?
|
Pitch Perception | 1 | 2003 | 101 | 0.050 |
Why?
|
Nerve Block | 1 | 2009 | 706 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 2057 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1516 | 0.050 |
Why?
|
Logistic Models | 3 | 2011 | 13255 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2691 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2010 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 2226 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2917 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2011 | 1792 | 0.050 |
Why?
|
Anesthesiology | 1 | 2011 | 1120 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2169 | 0.040 |
Why?
|
Low Back Pain | 1 | 2009 | 984 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1654 | 0.040 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 635 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2006 | 3808 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2047 | 0.040 |
Why?
|
Young Adult | 9 | 2011 | 59255 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3416 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2576 | 0.040 |
Why?
|
Comorbidity | 2 | 2004 | 10508 | 0.040 |
Why?
|
Pain Measurement | 1 | 2009 | 3551 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1728 | 0.040 |
Why?
|
Lipids | 1 | 2009 | 3341 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2009 | 3466 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 3879 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6377 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 3980 | 0.040 |
Why?
|
Retrospective Studies | 13 | 2011 | 80646 | 0.040 |
Why?
|
Arousal | 1 | 2003 | 1166 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2004 | 2358 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2004 | 2707 | 0.030 |
Why?
|
Liver | 2 | 2009 | 7529 | 0.030 |
Why?
|
Data Collection | 1 | 2006 | 3322 | 0.030 |
Why?
|
RNA, Viral | 3 | 2009 | 2846 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3165 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2697 | 0.030 |
Why?
|
Treatment Outcome | 9 | 2011 | 64684 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2009 | 26127 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2011 | 15843 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9326 | 0.030 |
Why?
|
Cognition | 1 | 2011 | 6992 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 4251 | 0.030 |
Why?
|
Health Surveys | 1 | 2004 | 4061 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6346 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5872 | 0.030 |
Why?
|
Asthma | 1 | 2011 | 6234 | 0.030 |
Why?
|
Anesthetics, Combined | 1 | 2012 | 43 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5841 | 0.030 |
Why?
|
Spectrophotometry | 1 | 2012 | 309 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4920 | 0.020 |
Why?
|
Time Factors | 5 | 2011 | 39970 | 0.020 |
Why?
|
HIV Infections | 2 | 2009 | 17352 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11121 | 0.020 |
Why?
|
Hepatitis Antibodies | 1 | 2010 | 67 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2006 | 4330 | 0.020 |
Why?
|
Lung Volume Measurements | 1 | 2011 | 375 | 0.020 |
Why?
|
Viral Load | 2 | 2009 | 3332 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6534 | 0.020 |
Why?
|
Coloring Agents | 1 | 2012 | 562 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 4063 | 0.020 |
Why?
|
Hepatitis C Antibodies | 1 | 2009 | 146 | 0.020 |
Why?
|
Genotype | 3 | 2009 | 12990 | 0.020 |
Why?
|
Regression Analysis | 2 | 2010 | 6344 | 0.020 |
Why?
|
Neuralgia, Postherpetic | 1 | 2009 | 41 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2009 | 6815 | 0.020 |
Why?
|
Spinal Nerve Roots | 1 | 2009 | 121 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8540 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11742 | 0.020 |
Why?
|
Anesthesia, Spinal | 1 | 2011 | 280 | 0.020 |
Why?
|
Serologic Tests | 1 | 2010 | 381 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2006 | 1333 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2009 | 407 | 0.020 |
Why?
|
Altitude Sickness | 1 | 2008 | 91 | 0.020 |
Why?
|
Contact Lenses | 1 | 2009 | 138 | 0.020 |
Why?
|
APACHE | 1 | 2008 | 267 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 2009 | 160 | 0.020 |
Why?
|
Physical Stimulation | 1 | 2009 | 517 | 0.020 |
Why?
|
Weather | 1 | 2008 | 231 | 0.020 |
Why?
|
Biopsy | 2 | 2009 | 6766 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 494 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 764 | 0.020 |
Why?
|
Decision Trees | 1 | 2009 | 504 | 0.020 |
Why?
|
Hypothermia | 1 | 2008 | 188 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2003 | 5779 | 0.020 |
Why?
|
Death, Sudden | 1 | 2008 | 301 | 0.020 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2010 | 467 | 0.020 |
Why?
|
Hospitals, General | 1 | 2011 | 798 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 30054 | 0.020 |
Why?
|
Demography | 1 | 2011 | 1648 | 0.020 |
Why?
|
Family Health | 1 | 2011 | 1257 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9002 | 0.020 |
Why?
|
Prospective Studies | 4 | 2012 | 54426 | 0.020 |
Why?
|
Workflow | 1 | 2011 | 851 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1068 | 0.020 |
Why?
|
Software | 2 | 2011 | 4434 | 0.020 |
Why?
|
China | 1 | 2011 | 2374 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2011 | 575 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 2009 | 405 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12975 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2009 | 877 | 0.020 |
Why?
|
Prognosis | 3 | 2010 | 29629 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 931 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12463 | 0.010 |
Why?
|
Massachusetts | 2 | 2009 | 8830 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2010 | 909 | 0.010 |
Why?
|
Risk Assessment | 3 | 2011 | 23996 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2010 | 1071 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
Equipment Design | 1 | 2012 | 3511 | 0.010 |
Why?
|
Child | 5 | 2010 | 80156 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 1008 | 0.010 |
Why?
|
Checklist | 1 | 2011 | 827 | 0.010 |
Why?
|
Fasting | 1 | 2010 | 1603 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15266 | 0.010 |
Why?
|
Suture Techniques | 1 | 2008 | 769 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4542 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2880 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2218 | 0.010 |
Why?
|
Administration, Oral | 1 | 2011 | 4021 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6228 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 8002 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2644 | 0.010 |
Why?
|
Interferons | 1 | 2006 | 706 | 0.010 |
Why?
|
Risk Factors | 4 | 2011 | 74213 | 0.010 |
Why?
|
Program Evaluation | 1 | 2011 | 2495 | 0.010 |
Why?
|
Event-Related Potentials, P300 | 1 | 2003 | 149 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2915 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3597 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2010 | 1376 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3579 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2009 | 1902 | 0.010 |
Why?
|
Accidental Falls | 1 | 2008 | 1068 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4915 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2009 | 22176 | 0.010 |
Why?
|
Cholesterol | 1 | 2009 | 2904 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6965 | 0.010 |
Why?
|
Incidence | 2 | 2009 | 21355 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36429 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2006 | 2571 | 0.010 |
Why?
|
United States | 2 | 2008 | 72335 | 0.010 |
Why?
|
Sarcoma | 1 | 2010 | 1801 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1213 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4575 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6484 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2538 | 0.010 |
Why?
|
Random Allocation | 1 | 2003 | 2395 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7054 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9646 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8633 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2008 | 1998 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2009 | 4471 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8528 | 0.010 |
Why?
|
Stroke Volume | 1 | 2011 | 5496 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12059 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12341 | 0.010 |
Why?
|
Survival Rate | 1 | 2009 | 12725 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2003 | 1882 | 0.010 |
Why?
|
Mass Screening | 1 | 2010 | 5428 | 0.010 |
Why?
|
Artifacts | 1 | 2003 | 1911 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13510 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2008 | 5293 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9319 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2006 | 15633 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14666 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4878 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7391 | 0.010 |
Why?
|
Melanoma | 1 | 2010 | 5709 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6403 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17904 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 15732 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23447 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39107 | 0.000 |
Why?
|
Brain Mapping | 1 | 2003 | 6635 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 42230 | 0.000 |
Why?
|
Cohort Studies | 1 | 2009 | 41493 | 0.000 |
Why?
|